// App-Quantinova.ai

26-OR : Metabolic Benefits beyond Glycemic Control with Artificial Intelligence, Internet of Things, and Whole-Body Digital Twin: Initial Six Months Results of a Randomized Control Trial

Researchers

Presenter

  • SHASHANK R. JOSHI

Principal Investigators

  • LISA SHAH

  • Maluk Mohamed

  • Jahangir Mohammed

  • Terrence Poon

  • Mala Dharmalingam

  • Arun Vadavi

  • Banshi Saboo

  • Suresh Damodharan

  • Ashok Keshavamurthy

  • Mohamed Thajudeen

  • Suchitra Bhonsley

  • Paramesh Shamanna

Medical Centers

  • N/A

Locations

  • India

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

  • Gastroenterology (GU)

Disease

  • Diabetes

  • Coronary Artery Disease

  • Nonalcoholic fatty liver disease

Biomarkers

  • Estrogen receptor alpha

  • GC Vitamin D Binding Protein

  • Hemoglobin A1c

  • High sensitivity C-reactive protein

  • Sex hormone binding globulin

  • White Blood Cell

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved